Natco Pharma launches Carboplatin injection in US, shares rise 2%
Natco Pharma shares rose over 2% on Monday, October 19, after the company announced the launch of Carboplatin Injection, a generic version of Paraplatin, in the US market through its subsidiary Natco…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.